Patents by Inventor Mathieu Noteborn

Mathieu Noteborn has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20080103099
    Abstract: The invention relates to the field of apoptosis. The invention provides novel therapies, for example, novel combinatorial therapies or novel therapeutic compounds that can work alone, sequentially to, or jointly with Apoptin, especially in those cases wherein p53 is completely or partially non-functional.
    Type: Application
    Filed: October 1, 2007
    Publication date: May 1, 2008
    Applicant: Leadd B.V.
    Inventors: Mathieu Noteborn, Astrid Danen-van Oorschot, Jennifer Rohn, Bertram Weiss, Luisella Toschi
  • Publication number: 20060073160
    Abstract: Recombinant genetic information (DNA or RNA), comprising a Chicken Anemia Virus (“CAV”)-specific nucleotide sequence and the use thereof for diagnostics, vaccination or protein production. Recombinant CAV protein and the use thereof for diagnostics, vaccination or production of CAV-specific antibodies. The use of CAV-specific antibodies thus obtained.
    Type: Application
    Filed: September 28, 2005
    Publication date: April 6, 2006
    Inventors: Mathieu Noteborn, Gerben de Boer